The Swiss RAG issued guidance for underwriters how to evaluate the insurance requests of those who show signs of the use of medicines for longevity purposes.
Swiss Rey said that metframeen is traditionally used for type 2 diabetes management, and is part of an increased list of materials sought for aging purposes, an immunoscopic, rapemicin, prepared for organ transplant recipients. In some cases, the insurance company said that the medicine is being prescribed itself.
Swiss Rai has updated its Life Guide, used by more than 800 insurance companies and supports more than 23 million underwriting questions annually. The company said some drugs possess uncertainty.
In a statement on Monday, Natalie Kelly, head of Swiss R. World Undrawading, said, “With re -prepared medicines, clinical photo is still being prepared.” “This refreshing provides practical support to the decisive support to the Anderbuilders-especially in cases where the use of these drugs can be experimental or itself.”
Photo: Metframeen tablets; Photo Credit: Scott Olson/Getty Images
Related:
Copyright 2025 Bloomberg.
Was this article valuable?
These are more articles you can enjoy.
Is interested Drug?
Get automatic warnings for this title.
